CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Celltrion, Incorporation Company Snapshot
Celltrion, Incorporation operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Celltrion, Incorporation with three other companies in this sector in South Korea: Samsung Biologics Co Ltd (2018 sales of 535.81 billion Korean Won [US$444.18 million] of which 99% was Antibody Drugs), Green Cross Corporation (1.33 trillion Korean Won [US$1.11 billion] of which 86% was Greencross), and Celltrion HealthCare Co Ltd (713.49 billion Korean Won [US$591.48 million] of which 96% was Goods Sales).

Sales Analysis. Celltrion, Incorporation reported sales of 982.07 billion Korean Won (US$814.14 million) for the year ending December of 2018. This represents an increase of 3.5% versus 2017, when the company's sales were 949.08 billion Korean Won. Sales at Celltrion, Incorporation have increased during each of the previous five years (and since 2013, sales have increased a total of 334%). Sales of Chemical Business Division saw an increase that was more than double the company's growth rate: sales were up 7.7% in 2018, from 129.53 billion Korean Won to 139.47 billion Korean Won. Not all segments of Celltrion, Incorporation experienced an increase in sales in 2018: sales of Other Segment fell 12.9% to 7.70 billion Korean Won. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Celltrion, Incorporation
  Stock Performance Chart for Celltrion, Incorporation
 
  Stock Data: Recent Stock Performance:
  Current Price (8/16/2019): 154,000
(Figures in Korean Won)
1 Week -1.0%   13 Weeks -16.5%  
4 Weeks -21.2%   52 Weeks -40.3%  
 
Celltrion, Incorporation Key Data:
  Ticker: 068270 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 982,074,959,799
(Year Ending Jan 2019).
Employees: 1,074
  Currency: Korean Won Market Cap: 19,588,413,460,000
  Fiscal Yr Ends: December Shares Outstanding: 127,197,490
  Share Type: Common Closely Held Shares: 42,199,219
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.